Research study · Supportive Care in Cancer · 2026
Cannabis stigma and symptom management considerations in cancer survivors: a mixed-methods exploration of patient perspectives
Verified on PubMed Oxford CEBM Level 2B: Clinical Cohort Study
A 2026 observational study in Supportive Care in Cancer tested medical marijuana in cancer. The results showed that most people held positive attitudes toward cannabis and did not feel personally judged for using it. This study highlights that while social judgment around cannabis is less common than expected among cancer survivors, communication barriers between patients.
In plain language
Study overview
Researchers investigated what cancer survivors think about using cannabis and whether they worry about being judged for it. They interviewed and surveyed adults who had finished cancer treatments, comparing those who used cannabis to manage symptoms with those who did not.
Findings
The results showed that most people held positive attitudes toward cannabis and did not feel personally judged for using it. However, a few patients still chose to hide their cannabis use from their doctors out of caution, while many expressed deep concerns and shame regarding prescription pain medications.
Explore Dr. Caplan's interactive tool detailing cytochrome P450 pathways, clinical titration intervals, and physician surveillance rules.
The deeper readScientific analysis
Purpose This study aims to assess for indications of stigma and attitudes toward cannabis among cancer survivors (CS) who use or consider the use of cannabis. Methods This study employed a convergent, parallel mixed methods design utilizing focus group and questionnaire data to assess the presence of stigma among a sample of CS (n=23) who use (n=10) and do not use (n=13) cannabis to manage symptoms. CS were recruited from a multi-site observational study in the Northeast U.S. region that assesses cannabis use among oncology patients. Results A total of 23 CS participated in this study. In general, this sample appeared to have positive attitudes towards cannabis, as indicated by quantitative results, and most CS felt accepting or neutral about other CS using cannabis, irrespective of whether they used or not. Most CS did not indicate experiences of stigma for cannabis use, did not feel judged by their medical providers, and indicated a feeling of empowerment to do whatever was needed to feel better. However, several CS reported intentional nondisclosure to their providers. Many CS discussed the presence of opioid-related stigma, both perceived from society and internalized, which appeared to play an important role in their symptom-management decision-making. Conclusions Findings from this study suggest that while cannabis stigma may not be commonplace for CS, some do experience it. Further, opioid stigma appears to be perceived and intertwined in the decision-making processes for CS in this sample.
The paper
Citation
Levy S, Meghani S, Worster B, Kilanowski C, Smith D, Case AA, et al. Cannabis stigma and symptom management considerations in cancer survivors: a mixed-methods exploration of patient perspectives. Supportive Care in Cancer (2026). PubMed 41820694 · DOI
Limitations the authors noted
Participants who enrolled in cannabis-related studies may inherently be more comfortable discussing the topic. Sample reflects perspectives from individuals in only two states with established medical cannabis laws, limiting broader geographic generalizability. Use of focus groups rather than individual interviews introduces potential risks for social desirability bias and group conformity effects. Small sample size creates a possibility of type II error.
In practice
Why this matters
This study highlights that while social judgment around cannabis is less common than expected among cancer survivors, communication barriers between patients and doctors still exist. It demonstrates that fears surrounding prescription pain medications heavily influence why patients seek out alternative plant-based options. Clinicians should take note that patients benefit greatly from safe, open conversations about all symptom relief methods without fear of judgment.
Frequently asked questions
Clinical Questions & Answers
What were the primary clinical findings regarding Medical cannabis and Cancer?
The results showed that most people held positive attitudes toward cannabis and did not feel personally judged for using it. However, a few patients still chose to hide their cannabis use from their doctors out of caution, while many expressed deep concerns and shame regarding prescription pain medications.
What study limitations or clinical safeguards should patients keep in mind?
Participants who enrolled in cannabis-related studies may inherently be more comfortable discussing the topic. Sample reflects perspectives from individuals in only two states with established medical cannabis laws, limiting broader geographic generalizability. Use of focus groups rather t...
Browse related research
Condition: Cancer Condition: Social stigma Topic: Medical cannabis Topic: Opioid
Related on CED Clinic
Back to Daily Research and Patient Questions
Reviewed by Dr. Caplan on October 29, 2026.
This page is general education about a published study. It is not medical advice and does not create a doctor-patient relationship. For care specific to you, book a consultation.